Posted by AGORACOM-JC
at 9:00 PM on Sunday, June 28th, 2020
(TSXV: BABY)
Company Highlights
$CAD 10 million cash and runway for well over a year;
Backed By A Billion Dollar Global Nutrition Company;
MOU For International Distribution Of Products
US Launch of Trial-Sized Pouches Ongoing
US Product Launch Planned For Q3-2020;
“Best Health” Award At Global Food Innovation Summit In Milan;
Awarded Patents In 22 Countries, 44 Countries Pending;
Executives & Advisors From Globally Renowned Companies & Institutions
Finding the right balance of healthy foods to promote optimal childhood growth and development can be a challenge for many parents. Else’s plant-based toddler nutritional drink is a minimally processed product that provides vitamins, plant-based proteins, and healthy fats. With so many available foods that are low in nutritional value, this product is a welcome addition to the market.”
Dr. Leah Alexander, MD, FAAPQ: What are the ingredients in Else Toddler Nutrition Drink? A: Else Plant-Based Toddler Nutrition Drink contains almond butter, buckwheat flour, tapioca maltodextrin and vitamins and minerals. It is slightly sweetened with less than 2% of sugar – significantly less than traditional offerings. Â
Q: Why are almond and buckwheat proteins better than those found in soy? Â
A: The combination of almond and buckwheat proteins provide a full range of amino acid. Most soy is genetically modified and may also be difficult to digest.  Â
Q: Will my toddler get all nutrients required for her/his needs?
A: Yes. Else Plant-Based Toddler Nutrition Drink offers a similar caloric and macronutrient profile to breask milk, making it a great option to supplement your toddler’s diet. It was designed to provide complete nutrition, with nutrients and vitamins to support growth and development.
FULL DISCLOSURE: Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 8:49 AM on Friday, June 26th, 2020
SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.
HADO: The Amazing Ways Augmented Reality Is Changing Sport
Now that Japanese start-up Meleap created the world’s first physical e-sport called HADO, gamers have a way to be active while competing in the digital world
HADO is an entirely new experience the company calls techno sports that uses augmented reality (AR) tech and motion sensors without requiring the player to be tethered to a gaming system, controllers, or cables
Now that Japanese start-up Meleap created the world’s first physical e-sport called HADO, gamers have a way to be active while competing in the digital world. HADO is an entirely new experience the company calls techno sports that uses augmented reality (AR) tech and motion sensors without requiring the player to be tethered to a gaming system, controllers, or cables. The company has three AR offerings, including HADO Augmented Sport (Player vs. Player), HADO Monster Battle, and HADO Shoot; they will soon add HADO Kart.
HADO: The Amazing Ways Augmented Reality Is Changing Sport
First Experience to Merge Physical Athletics with AR Technology
In HADO Augmented Sport, you can see how physical the game can be. It resembles dodgeball with players competing in an arena and flipping and bending to avoid being hit by the opposing team’s energy balls. Competitors can play 1v1, 2v2, or 3v3. Each team stays on one side of the court. The goal is to hit the other team with as many energy balls as possible to drain them of their “lives” and get points during a timed event.
Players can defend themselves with shields and barriers. If the shields get hit, they will weaken and ultimately need to be recharged. If you remember playing dodgeball, there is a lot of ducking and diving in HADO, just as there is in the traditional dodgeball game. Quick reflexes and coordination are necessary to avoid being hit. Players also have the option to alter their play characteristics to become more defensive (shields get stronger, but a slower recharge time for attacks) or offensive (quick recharge time after attacks, but shields are weaker). In addition to shield thickness and recharge speed, players can alter the bullet size. These adjustments can allow for different players on the same team to play different strategic roles in the competition.
AR of HADO
The digital experience is enabled by an AR device that players wear on their heads and a motion sensor the size of a smartphone worn on the wrist or forearm. Players are able to move unrestricted in the real environment while interacting with the digital items they can see through the AR headset. This is not a sport played in your living room, but in 60+ arenas in 15 countries that give ample space for the competition similar to other physical sports such as volleyball and basketball. AR tech is also lighter weight, so players can dive and move without feeling weighed down. The possibilities allowed through AR make applications for HADO’s e-sport virtually unlimited.
Physical Fitness with HADO
HADO requires players who are physically agile and have gaming skills as well. Players who succeed at the game will be in constant motion while diving, bending, and squatting to evade the energy balls hurled by the other team. When players shoot energy balls, they use a punching motion. Players must have great hand-eye coordination and be adept at blocking from a variety of angles. There are VR games such as Sparc and Audioshield that can help players with hand-eye coordination training required to be good at HADO.
Global Expansion
HADO has held several competitions and events in Asia, including the HADO World Cup tournament where the world’s top players compete for a cash prize and bragging rights as the HADO World Champions. There are plans to expand globally by 2020. Currently, 600,000 users have experienced HADO sports.
HADO is launching a pro AR league in Japan this year as well. Tournaments are planned every week and will award a cash prize to the winners. The first official season of the pro league begins in the third quarter of 2019.
As this new concept of e-sports gains popularity, a HADO arena might open near you, where you will be able to compete with other players locally to see what it’s all about. Until then, you can watch YouTube to see players in action.
Not only did Meleap make many childhood dreams come true with the creation of HADO and by bringing virtual and physical realms together, but they proved that AR technology and athletic sports can be combined for an entirely new experience. It will be interesting to watch as others apply these concepts to other sports competitions and use cases in a variety of industries.
Posted by AGORACOM-JC
at 7:12 AM on Friday, June 26th, 2020
Announced definitive agreement with Allied Corp. to manufacture and distribute throughout California products targeted at veterans and first responders under the brand Tactical Relief ™
The first products to be manufactured will feature products that are recognized for their medicinal properties in the treatment of Post Traumatic Stress Disorder (PTSD)
VANCOUVER, British Columbia, June 26, 2020 —Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB) (the “Company†or “Hollisterâ€) is pleased to announce that further to the press release dated February 7th, 2020, through it’s subsidiary, Hollister Cannabis Co. has on June 22nd, 2020 signed a definitive agreement (the “Agreementâ€) to bring to market with Allied Corp. (“Alliedâ€) a pipeline of products that are targeted towards helping veterans and first responders. These products will be brought to market under the brand Tactical Relief™, a veteran-founded hemp-based CBD oil brand owned by Allied Corp. (OTCQB: ALID).
Branded under Tactical Relief™, the first products to be manufactured will feature products that are recognized for their medicinal properties in the treatment of Post Traumatic Stress Disorder (PTSD). True to Hollister’s mission, the products will be crafted in small, artisanal batches for optimal quality and made from premium California-grown cannabis.
Under the terms of the Agreement, Allied will contribute the Tactical Relief™ brand support including use of trademark, artwork, logos and package design for a series of products. On an ongoing basis, Allied will be financially responsible for all marketing design and support. Hollister will be responsible for all aspects of production and procurement of underlying materials. Hollister will also be responsible for all costs associated with distribution and sales support. All production of cannabis products will take place under Hollister’s supervision and licenses. Allied and Hollister will further explore the development and marketing of additional products, as well as expanding into additional regions within the United States over the coming years.
The new Tactical Relief™ products will be distributed exclusively by Hollister’s distribution partner, Indus Holdings Inc. (CSE: INDS), and is anticipated to be in retail locations throughout California within quarter three of 2020. An estimated 5% of net profits from all sales will be donated to charity. The remaining revenue generated from the sale of the products will be shared 60:40 between Hollister and Allied.
“This partnership is one that unites two powerful companies in the cannabis space with one common mission: to help veterans and first responders change the way they manage PTSD and TBI. This is a huge shift that has to happen nationwide. This partnership is the start of that shift,†said Adam Smith, VP Natural Health at Allied Corp.
Carl Saling, Hollister’s CEO stated: “We are thrilled to be working with Allied Corp. to bring much needed relief to our amazing veterans and 1st responders with PTSD and other ailments. This is a very important mission for Hollister to be able to have a huge impact on our veteran’s lives.â€
About the Tactical Relief™ Brand
Led by a Green Beret and trainer of law enforcement, the Tactical Relief™ brand creates, promotes and sells high quality and patriotic CBD oils throughout the country. Allied’s CBD oils are full spectrum and are currently made from the highest quality hemp grown in Kentucky. Adam Smith (VP of Natural Health for Allied Corp.) is a Green Beret with nearly 17 years in service and experienced firsthand how CBD can help veterans and active-duty (military and first responders) ease their physical and mental stress due to post traumatic stress disorder and traumatic brain injury. Tactical Relief™ is on a mission to end the stigma around hemp and cannabis products, and to provide relief to as many service members as possible.
Allied Corp. is an international medical cannabis production company with a mission to address today’s medical issues with a primary focus on Post Traumatic Stress Disorder in veterans and first responders. Allied helps those who have served by researching, developing and producing targeted cannabinoid health solutions for those who need them. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant-based production and unique development of therapeutic products.
Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.â€
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statementsâ€. The use of any of the words “anticipateâ€, “continueâ€, “estimateâ€, “expectâ€, “mayâ€, “willâ€, “wouldâ€, “projectâ€, “shouldâ€, “believe†and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com
Tags: Cannabis, CBD, CSE, Hemp, small cap Posted in All Recent Posts, Featured, Hollister Biosciences | Comments Off on Hollister Biosciences Inc. $HOLL.ca and Allied Corp. sign Definitive Agreement for Distribution of Products Under Veteran Based Brand: Tactical Relief™ $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca
Posted by AGORACOM-JC
at 2:30 PM on Thursday, June 25th, 2020
Announced the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors
Benj has worked with start-ups and corporations of various sizes.
He has built his company over 25 years and understands the buy side in great detail, as well as corporate turnarounds
His background in investments greatly strengthens our company,†stated Marshall Gunter, CEO of Datametrex. “Benj is highly accomplished and connected within the investor community.â€
TORONTO, June 25, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF)Â is pleased to announce the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors.
“Benj has worked with start-ups and corporations of various sizes. He has built his company over 25 years and understands the buy side in great detail, as well as corporate turnarounds. His background in investments greatly strengthens our company,†stated Marshall Gunter, CEO of Datametrex. “Benj is highly accomplished and connected within the investor community.â€
To support Datametrex’s growth, Mr. Gallander brings over 40 years of experience in the markets, with ample skills in integrating business and strategic investors and his know-how bringing innovation to companies. Over time, he has refined his approach to investing and has achieved one of the best track records in the investment industry. Mr. Gallander is co-editor of Contra the Heard investment letter and over the past ten years the portfolio he manages achieved an annualized return of 18.4%. Benj co-writes “The Contra Guys” column for The Globe and Mail and is an author of three best-selling books, writes for several magazines, and has been a regular on BNN Bloomberg since virtually the beginning.
“Datametrex is poised to leverage their technology acumen and proven client solution capability. Datametrex’s recent initiative in COVID-19 testing kits has enabled the company to transform and breakthrough into society as a trusted and essential partner. I am looking forward to working with Marshall and the team at Datametrex,†said Benj.
The company has issued Mr. Gallander 1,000,000 options at a strike price of C$0.10, being the closing price of the common shares of the Company on June 24, 2020.
As part of Board changes, Charles Schade is stepping down from the Board and will be joining the Company’s Advisory Board. Charles joined the company from the start and was the longest serving Board member. The Company would like to thank Charles for his active contribution to the Board and looks forward to continuing to work with him as a member of the Advisory Board to the Company.
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information†within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “mayâ€, “willâ€, “expectâ€, “likelyâ€, “shouldâ€, “wouldâ€, “planâ€, “anticipateâ€, “intendâ€, “potentialâ€, “proposedâ€, “estimateâ€, “believe†or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may†or “will†happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 7:23 AM on Wednesday, June 24th, 2020
Company has completed shipping the second 10,000 purchase order of COVID-19 test kits to a Canadian based mining company with operations worldwide
Total gross sales amount is approximately $500,000 CDN, excluding shipping fees
Datametrex anticipates that it has little or no upfront costs associated with the sale of these test kits
TORONTO, June 24, 2020 —Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that the Company has completed shipping the second 10,000 purchase order of COVID-19 test kits (the “PO”) to a Canadian based mining company with operations worldwide.
The total gross sales amount is approximately $500,000 CDN, excluding shipping fees. Datametrex anticipates that it has little or no upfront costs associated with the sale of these test kits. All of the items are shipped from manufacturers to the purchaser’s mine operating sites in Ontario and Quebec.
Under the terms of the PO, Datametrex provides them with an initial 10,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1dropâ€), 10,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company also shipped two (2) Real-Time Polymerase Chain Reaction Detection System (“PCRâ€) machines along with software to ensure optimal assay performance of the samples.
“I think our industry has taken COVID-19 extremely seriously,†said Pierre Gratton, President and Chief Executive officer of the Mining Association of Canada to the Financial Post. “By implementing testing in their operations and conducting contact tracing of the infected individuals, this Mining conglomerate is closely monitoring the safety of its workers and surrounding communities to continue to operate responsibly and efficiently.â€
“Datametrex is proud of being at the forefront of COVID-19 testing technologies and is pleased to facilitate solutions to help contain the spread and a potential resurgence of the virus,†says Marshall Gunter, CEO of the Company. “We want to help companies in the process of curtailing the second wave threatening society and the global economy.â€
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information†within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “mayâ€, “willâ€, “expectâ€, “likelyâ€, “shouldâ€, “wouldâ€, “planâ€, “anticipateâ€, “intendâ€, “potentialâ€, “proposedâ€, “estimateâ€, “believe†or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may†or “will†happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 7:15 AM on Monday, June 22nd, 2020
Plant-based Complete Nutrition for Toddlers Trial Pouches to be widely available on ElseNutrition.com e-store
(1.27 oz) will be available at no charge, with customers covering only the shipping costs
The sampling campaign will be promoted via Else social media channels and will precede the launch of the full-size version of the product, which will be available for pre-orders on our e-store this July
VANCOUVER, BC, June 22, 2020 - ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company“), is pleased to announce the U.S. launch of trial-sized pouches of Else Plant-based Complete Nutrition for Toddlers.
Following successful production, the trial samples of Else’s proprietary product will now be widely available for order via the elsenutrition.com e-store.
“We are thrilled to hit this key milestone and to be sharing our product with the world. It is indeed a major inflection point as we continue down the path toward commercialization of our first product. We are excited to get the samples in the hands of eager parents looking for clean label, plant-based nutrition alternatives for their children,” said Ms. Hamutal Yitzhak, CEO & Co-Founder.
Else Plant-Based Complete Nutrition for Toddlers trial pouches (1.27 oz) will be available at no charge, with customers covering only the shipping costs. The sampling campaign will be promoted via Else social media channels and will precede the launch of the full-size version of the product, which will be available for pre-orders on our e-store this July.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executive and Advisory Board includes leaders hailing from Abbott Nutrition, Mead Johnson, Boston Children’s Hospital, ESPGHAN (European Society for Pediatric Gastroenterology, Hepatology and Nutrition), University Hospital Brussels, Tel Aviv University’s Sackler Faculty of Medicine, and Gastroenterology & Nutrition Institute of RAMBAM Medical Center, Plum Organics.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Posted by AGORACOM-JC
at 4:18 PM on Friday, June 19th, 2020
Else Nutrition Holdings Inc. (TSX-V: BABY) The award winning, plant-based nutrition company for small cap investors. The company has a $10,000,000 cash balance for US product launch In Q3 2020 with International agreements to follow. Learn More
A Novel Product for Child Nutrition
ELSE stands out as a unique supplemental beverage for 3-12 year-olds
It has the essential vitamins and nutrients that many children lack in their usual diets
Unlike competitor products, ELSE contains no milk or soy proteins, also making it ideal for kids with such allergies
by Dr. Leah Alexander
Ensuring that a child has a balanced, healthy diet can be a challenge for parents. Every family situation is different, but a variety of factors can prevent children from eating nutritious foods. Some families live in communities where access to fresh food markets is limited. Instead, fast food establishments and convenience stores are the only local food sources. Other families live in areas of food shortages due to climate effects, civil unrest, or poverty. In other cases, it is simply that a child has developed taste preferences for high fat, sweetened, and salty foods due to introduction during the toddler years. Whatever the reason, a report by The United Nations Children’s Fund (UNICEF), “State of the World’s Children 2019,†shows some startling statistics (source):
1 in 3 children under the age of 5 are either undernourished or overweight, resulting in stunting of growth, muscle wasting, and obesity
1 in 2 children suffers from “hidden hunger,†deficiencies in vitamins and essential nutrients
1 in 5 children aged 5 to 19 are considered overweight (BMI >19)
The World Health Organization’s analysis provides similar results (source). Children worldwide are not consuming the proper nutrients in their diets.
A healthy diet is important for optimal growth and cognitive development. Calcium absorption for maximum bone density, increase in muscle mass, and brain maturation occurs throughout childhood. If the appropriate nutrients are lacking, these important milestones are affected. Iron, in particular, is important for brain function; research has shown reduced academic achievement in the presence of iron deficiency (source). Unfortunately, children are not consistently eating enough of the right kinds of foods. According to the Centers for Disease Control and Prevention (CDC), calories from added sugars and fats contribute to 40% of the daily caloric intake for children aged 2 to 18 (source). The primary sources of these calories come from soda, fruit drinks, desserts, pizza, and whole milk. Based on this, it is clear that improvements need to be made regarding global child nutrition.
The WHO recommends a balanced diet of grains or tubers (i.e. potatoes, yams), legumes, vegetables, fruits, and proteins (source). Vegetables and fruits provide essential vitamins, minerals, fiber, plant protein, and antioxidants. These all lower the risk of obesity, heart disease, type II diabetes, and some forms of cancer. A diet with adequate protein is important for both muscle and tissue building. How much of each food group a child should eat varies by age, gender, and amount of physical activity (source). When too much or too little are consumed, the risk of health-related illness increases.
A Pediatric Perspective
In clinical practice, I have witnessed a variety of childhood eating habits. In the best scenario, some children seem to naturally be “healthy eaters,†enjoying any food put on the plate. Other kids prefer only fruits, therefore, missing the nutrients vegetables would provide. Then, there are children who will only eat a few foods from each food group. While some of these “selective eaters†have a diagnosed developmental disorder or autism, many do not. Additionally, there seems to be a preference for what I call the “Kid Junk Food Trifectaâ€: chicken nuggets, macaroni and cheese, and pizza. The chicken nuggets are typically from a fast-food establishment, the macaroni is the “boxed†version, and, by pizza, it means only dough, sauce, and cheese. Although there are many theories as to why children may refuse healthy foods, research has shown an association of food marketing with unhealthy food choices. Advertisers promote products that are kid-friendly but often low in nutritional value (source). When seen often enough, children find the advertised food to be more appealing, choosing it over healthier options.
Efforts to Improve the Current Trends in Child Nutrition
In order to address the UNICEF concerns about stunted growth during the early childhood years, nutritional beverages have been developed by infant baby formula companies. In theory, by offering a supplement with vitamins, proteins, fats, and carbohydrates, parents have another way to provide essential nutrients. Creative marketing has convinced many parents that these products are nutritious and beneficial. Examining the ingredients, however, there are some concerns. The second or third ingredient is often sugar. While this added sugar may give an appealing taste to the product, it can promote tooth decay and obesity. It also increases the likelihood of developing type II diabetes later in life. Although it may not have been the intention of the developers, the high sugar content of these beverages puts them in the category of a “sugary drink,†something the American Academy of Pediatrics discourages (source). The CDC agrees, stating that no more than 10% or 200 calories of one’s total daily calories should come from sugar (source). The currently available nutritional beverages contain 12-18% sugar, much more than is recommended. Fortunately, there is a much better option, ELSE.
Else Plant-Based Kids Nutritional Drink
ELSE stands out as a unique supplemental beverage for 3-12 year-olds. It has the essential vitamins and nutrients that many children lack in their usual diets. Unlike competitor products, ELSE contains no milk or soy proteins, also making it ideal for kids with such allergies. Those who follow a vegan diet will find this aspect appealing as well (some versions of the competitor product contain tuna oil). There are no artificial flavors in ELSE. As an added bonus, ELSE contains the essential fatty acids docosahexaenoic acid (DHA) and arachidonic acid (ARA). Although most important during the first 2 years of life, there is growing evidence of the benefits of DHA in older children and adults (source).
There are some special situations where ELSE may be beneficial. For example, children with inflammatory bowel disease often eat less due to abdominal pain, and their bowel inflammation impairs nutrient absorption. ELSE could be a source of nutrients that are difficult for these children to get. Young cancer patients suffering from anorexia during chemotherapy treatments may benefit from this product as well. In situations of food scarcity, such as during a natural disaster, ELSE could be a temporary, supplemental source of nutrition.
The WHO has set goals for child nutrition with the hope of meeting them by 2025. They seek to lower the rates of stunted growth under age 5, to reduce childhood wasting to less than 5%, and to stop the rise of childhood obesity (source). A healthier nutritional supplement such as ELSE may be just the product needed to help achieve these goals.
Posted by AGORACOM-JC
at 8:01 AM on Thursday, June 18th, 2020
Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies
Total gross sales of approximately $1.5 million CAD
Datametrex has little or no upfront costs associated with the sale of these test kits
Company’s project pipeline is significant on both the COVID-19 test kits and Personal Protective Equipment based on multiple projects in various stages of development across Canada, US, Africa, Asia, Australia and the EU
TORONTO, June 18, 2020 – Datametrex AI Limited (the “Company†or “Datametrexâ€) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to share a corporate update that since announcing on April 16, 2020, that it secured the rights to import and sell high-quality South Korean manufactured Nucleic Acid COVID-19 test kits.
Datametrex continues supporting companies through facilitating COVID-19 test kits, along with big data AI analytics tools that can help target future outbreaks, potentially source fake news that can be detrimental to the operations, or even visualize the audience that needs the fastest response in these critical times.
NEW REVENUE
The Company has sold approximately 30,000 test kits and 7 PCR (Polymerase Chain Reaction) machines to several Canadian companies, for total gross sales of approximately $1.5 million CAD. Datametrex has little or no upfront costs associated with the sale of these test kits.
HIGHLIGHTS
Since May 15th, Datametrex has generated gross sales of $500,000 with the sale of 10,000 test kits and one (1) PCR machine to a large Canadian mining company with operations in West Africa.
Since June 8th, Datametrex has sold $810,000 with initial orders comprising of 12,000 test kits and six (6) PCR machines to two Canadian companies.
On June 9th the Company arranged with lab partner Transpharm Canada Inc. (“TCIâ€) to conduct ongoing testing for a private Quebec metal mining company with an initial order of 2,000 test kits generating gross sale of approximately $250,000 for Datametrex.
“With the resurgence of a second wave of COVID-19 in multiple countries, and with a worldwide attempt to reduce lockdown measures to get citizens back to work, the demand for testing will only increase. These rapid antibody-based tests are a vital tool for jumpstarting the economy,†says Marshall Gunter, CEO of the Company. “Datametrex is pleased to facilitate the sale of these test kits globally providing worldwide, the opportunity to use top quality test kits to flatten the curve and get back to the “new normal†safely.â€
Advisory Board and New Personnel
On May 4th, Todd Shapiro consented to join the Board of Directors of Datametrex. After being a top rated Radio Show host & a brilliant marketing Entrepreneur with over 20 years of experience, he has recently moved on from main stream media to concentrate his efforts on being the CEO of Red Light Holland. Todd currently sits on the Board of Directors for Red Light Holland, JamStacked and Mogul Productions.
On May 19th, Datametrex added President and Dean of the Toronto Institute of Pharmaceutical Technology (“TIPTâ€) and Clinical Pharmacologist, Dr. Alexander MacGregor, Ph.D., to the Company’s Medical Advisory Board.
On June 10th, the Company welcomed Edward Choi, to head up the sales team in Seoul, South Korea. Edward was a Vice President at LOTTE for leading Lotte’s cyber security division.
Datametrex Pipeline
The Company’s project pipeline is significant on both the COVID-19 test kits and Personal Protective Equipment (“PPEâ€) based on multiple projects in various stages of development across Canada, US, Africa, Asia, Australia and the EU. We are waiting for PO approvals with specified COVID-19 sales and or tender proposal process. The Company will recognize revenue upon sale and shipment of the test kits. The Company will also receive additional revenue streams as we secure new business and continue to provide Ai services, fullfill contracts and or supply agreements to goverments, corporate customers upon fulfillment.
About Transpharm Canada Inc.
Transpharm Canada Inc. provides pharmaceutical education, technology, and research opportunities to students through its subsidiary, Toronto Institute of Pharmaceutical Technology, North America’s premier pharmaceutical training institute. The facility is also fully compliant Health Canada licensed Good Manufacturing Practice (“GMPâ€) manufacturing and testing facility and is a full-service clinical development business that provides clinical trial services to biotechnology companies. Additional information on TIPT is available at www.tipt.com
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact:
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information†within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “mayâ€, “willâ€, “expectâ€, “likelyâ€, “shouldâ€, “wouldâ€, “planâ€, “anticipateâ€, “intendâ€, “potentialâ€, “proposedâ€, “estimateâ€, “believe†or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may†or “will†happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 5:50 PM on Tuesday, June 16th, 2020
If you don’t know what Augmented Reality (AR) is, this quote from Apple CEO Tim Cook is all the motivation you need to get up to speed:
“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phoneâ€
AR is essentially a technology that lays digital images and graphics over the real world.
As the name implies, ImagineAR (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality Company that enables businesses to create their own mobile phone AR campaigns with no programming or technology experience. More than just lip service, the Company recently announced a partnership with the Broward Education Foundation to create #2020gradsecret – an immersive augmented reality (AR) mobile experience for students graduating from Broward County Public School. Â
Using the free ImagineAR app, grads are recording themselves in their homes accepting diplomas from Broward Schools Superintendent Robert Runcie, joining international music superstar Flo Rida for a congratulatory message or dancing with either one of them-and instantly sharing the videos on social media. Adding in a congratulatory message is NBA superstar Dwyane Wayde.
Flo Rida stated “This futuristic ImagineAR augmented reality technology is a trip” “I’m happy to help these graduates define a new way of celebrating and social interaction as they move on to the next chapter in their young lives.”
How well is this Augmented Reality Diploma experience working out so far? Pejay Ryan, director of marketing for Broward Education Foundation said “The feedback has been off the hook. It is going to blow your mind.”
That quote is just the tip of the iceberg. Watch what Ryan has to say about why they selected ImagineAR and how “the sky is the limit on other applications”.
ImagineAR (IP:CSE) is the Augmented Reality company that allows small cap investors to participate in the growth of the space, which IP says is projected to grow ~ 2,000% in the next 4 years …. that is not a typo!
ImagineAR has already started commercializing their mobile Augmented Reality Platform with clients that include:
NBA Sacramento Kings
Mall Of America
AT&T Shape
Basketball Hall Of Fame
….. more
As a result, ImagineAR is now well positioned to further commercialize and capitalize on massive demand for Augmented Reality.
If our interview with CEO Alen Paul Silverrstieen and Pejay Ryan is any indication, it sounds like the Company’s growth into the education / graduation business is all but assured in 2020 and well beyond.
Posted by AGORACOM-JC
at 8:11 AM on Tuesday, June 16th, 2020
– Secured non-exclusive rights to sell RapiGEN Inc. (“RapiGENâ€) COVID-19 home test kitsi.
– These test kits are FDA registered, suitable for point of care testing, no extra equipment is needed, and are easy to use with results in 5-10 minutes.
TORONTO, June 16, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has secured non-exclusive rights to sell RapiGEN Inc. (“RapiGENâ€) COVID-19 home test kitsi. These test kits are FDA registered, suitable for point of care testing, no extra equipment is needed, and are easy to use with results in 5-10 minutes.
If the specimen contains IgM antibodies to SARS-CoV-2, a colored line appears in the T line area. The RapiGen home test kit is a lateral flow immunochromatographic assay (LFIA) for the qualitative detection of IgG antibodies to COVID19 in blood, serum or plasma specimens.
The Company’s primary goal is to sell to the current clients for their operations out of Canada, and the Company intends to apply for Health Canada approval with an Interim Order (“IOâ€).
“These test kits are revolutionary in expediting the process of testing since it cuts out the processing time by a fraction, aiding in an earlier detection of the virus, a more accurate prediction of the positive cases and a decrease of the infection rate,†said Marshall, CEO of the Company.
“Having seen the urgent need for COVID-19 test kits, Datametrex is doing everything it can to help Canada combat COVID-19 and flatten the curve. In the meantime, having FDA registration under EUA allowing us to help our neighbours to the south and any Canadian company with operations in the US and Europe,” says Andrew Ryu, Chairman of the Company.
The Company’s ability to fulfill any purchase order for Covid-19 test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits.
The Company is exploring oportunities with Michigan Economic Development Corporation and Governor’s Office of Business and Economic Development in California looking into retail, film, healthcare oportunities. With months into the spread of the COVID-19 in Califoria, widespread diagnostic testing still isn’t available. Testing voids, stemming from an overwhelmed supply chain and a disjointed public health system, have hit hardest in California’s rural north. The Michigan Department of Health and Human Services, Michigan State Police, and local health departments are looking to expand COVID-19 testing directly to the community. Michegan now is easing coronavirus restrictions with six-part reopening plan that includes testing to ensure the state lowers the chance of a second wave and to further protect Michigan families.
About RapiGEN Inc. RapiGEN has the manufacturing technology of Gold colloid which is the core material of immunochromatographic assay. RapiGen has developed a convenient, quick and accurate diagnostic kit, focused on developing distinctive next-generation diagnostic kits from existing products. Currently researching and developing various diagnostic kits for increasingly epidemic pathogenesis such as Covid-19, Shigella, Cholera and Entrohemorrhagic E.coli. Additional information on RapiGEN is available at http://rapigen-inc.com/
About Food and Drug Aministration EUA On February 4, 2020, pursuant to Section 564(b)(1)(C) of the Act, the Secretary of the Department of Health and Human Services (HHS) determined that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and that involves the virus that causes COVID-19. Pursuant to Section 564 of the Act, and on the basis of such determination, the Secretary of HHS then declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the virus that causes COVID-19 subject to the terms of any authorization issued under Section 564(a) of the Act.
About Datametrex Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
i Source: FDA [RAPIGEN INC] – BIOCREDIT COVID-19 IgG+IgM Duo -https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=680769&lpcd=QKO
